 - Surgically or medically castrated, with testosterone levels of 50 ngdL 2.0 nmolL. If the patient is being treated with luteinizing hormone-releasing hormone LHRH agonists patients who have not undergone orchiectomy, they must remain on continuous androgen suppression therapy throughout the study 